ELIGIBLE (Efficacy of Left atrIal Appendage Closure After GastroIntestinal BLEeding)

Patients with atrial fibrillation requiring anticoagulation treatment are at high risk of gastrointestinal bleeding. The investigators propose the percutaneous stop the oral anticoagulation and closur...

Lead sponsor: Hospital Clinic of Barcelona•6 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Victoria Martín Yuste, MD, PhD

CONTACT

+34-93-227-55-19 vmartiny@clinic.ub.es

Trial snapshot

StatusUNKNOWN

PhasePHASE3

Enrollment120

Start dateFeb 2012

Last updatedJun 26, 2012

Locations shown

Hospital Infanta Cristina

Badajoz, Badajoz

Fundació Clínic per a la Recerca Biomèdica

Barcelona, Barcelona

Hospital de La Paz

Madrid, Madrid

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 26, 2012Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions